First Study in Humans With GSK424887

NCT01059591 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

26

Enrollment

INDUSTRY

Sponsor class

Conditions

Depressive Disorder and Anxiety Disorders

Interventions

DRUG: GSK424887
DRUG: Placebo
RADIATION: PET

Sponsor

GlaxoSmithKline